SELECTED RELEVANT PUBLICATIONS

EXPLORING THE ROLE OF STROMAL OSMOREGULATION IN CELLULAR TRANSFORMATION IN CANCER AND DISEASE USING
EXECUTABLE MODELLING

David Shorthouse, Angela Riedel, Emma M. Kerr, Carla P. Martins, Jacqueline Shields, Benjamin A Hall

Nature Communications (1st August 2018)

THE ERBB NETWORK FACILITATES KRAS-DRIVEN LUNG TUMORIGENESIS

Bjorn Kruspig, Tiziana Monterverde, Sarah Neidler, Andreas Hock, Emma M. Kerr, Colin Nixon, William
Clark, Ann Hedley, Craig Dick, Karen Vousden, Carla Martins, and Daniel Murphy
Science Translational Medicine (20th June 2018)

METABOLIC REWIRING IN MUTANT KRAS LUNG CANCERS

Kerr EM, Martins CP.
FEBS J. (8th Jan 2018)
2018;285(1):28–41. doi:10.1111/febs.14125

LUNG TUMORS WITH DISTINCT P53 MUTATIONS RESPOND SIMILARLY TO P53-TARGETED THERAPY BUT EXHIBIT GENOTYPE-SPECIFIC STATIN SENSITIVITY

Frances K. Turrell, Emma M. Kerr, Meiling Gao, Hannah Thorpe, Gary J. Doherty, Jake Cridge, David Shorthouse, Alyson Speed, Shamith Samarajiwa, Benjamin A. Hall, Meryl Griffiths, and Carla P. Martins
Genes & Development (1st July 2017)
31: 1339-1353; Published in Advance August 8, 2017, doi:10.1101/gad.298463.117

MUTANT KRAS COPY NUMBER DEFINES METABOLIC REPROGRAMMING AND THERAPEUTIC SUSCEPTIBILITIES

Kerr, EM., Gaude, E., Turrell, FK., Frezza, C., Martins, CP.
Nature (3rd March 2016)
531, 110–113;  https://doi.org/10.1038/nature16967